Search research articles
Contact Us
Filters
Showing results (41-50 of 115) with videos related to
Page
of 12
Sort By:
Nature Communications
|
March 21, 2018
Glycogen synthase kinase 3 controls migration of the neural crest lineage in mouse and Xenopus
Sandra G Gonzalez Malagon, Anna M Lopez Muñoz, Daniel Doro, et al.
Cancer Cell
|
May 26, 2012
Distinct neural stem cell populations give rise to disparate brain tumors in response to N-MYC
Fredrik J Swartling, Vasil Savov, Anders I Persson, et al.
Nature Genetics
|
September 4, 2020
Subclonal reconstruction of tumors by using machine learning and population genetics
Giulio Caravagna, Timon Heide, Marc J Williams, et al.
Cancer Letters
|
September 23, 2024
Spliceosomal vulnerability of MYCN-amplified neuroblastoma is contingent on PRMT5-mediated regulation of epitranscriptomic and metabolomic pathways
Jodie Bojko, Madhu Kollareddy, Marianna Szemes, et al.
Molecular Cancer Therapeutics
|
June 24, 2026
Anti-Tumor Activity of Cdk2/9 Inhibitor Fadraciclib in an In Vivo Model of Temozolomide Refractory Neuroblastoma
Evon Poon, Tong Liang, Qiong Gao, et al.
Cancer Research
|
October 3, 2007
Malignant progression and blockade of angiogenesis in a murine transgenic model of neuroblastoma
Louis Chesler, David D Goldenberg, Isha T Seales, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2012
Phase I study of vincristine, irinotecan, and ¹³¹I-metaiodobenzylguanidine for patients with relapsed or refractory neuroblastoma: a new approaches to neuroblastoma therapy trial
Steven G DuBois, Louis Chesler, Susan Groshen, et al.
Oncotarget
|
June 25, 2020
MYCN expression induces replication stress and sensitivity to PARP inhibition in neuroblastoma
David King, Xiao Dun Li, Gilberto S Almeida, et al.
Oncotarget
|
September 18, 2014
Molecular rationale for the use of PI3K/AKT/mTOR pathway inhibitors in combination with crizotinib in ALK-mutated neuroblastoma
Nathan F Moore, Anna M Azarova, Namrata Bhatnagar, et al.
Open Biology
|
December 1, 2021
MYC regulates metabolism through vesicular transfer of glycolytic kinases
Alexia Tsakaneli, Victor Corasolla Carregari, Martina Morini, et al.
Page
of 12
Search research articles
Search
Showing results (41-50 of 115) with videos related to
Sort By:
Page
of 12
Nature Communications
|
March 21, 2018
Glycogen synthase kinase 3 controls migration of the neural crest lineage in mouse and Xenopus
Sandra G Gonzalez Malagon, Anna M Lopez Muñoz, Daniel Doro, et al.
Cancer Cell
|
May 26, 2012
Distinct neural stem cell populations give rise to disparate brain tumors in response to N-MYC
Fredrik J Swartling, Vasil Savov, Anders I Persson, et al.
Nature Genetics
|
September 4, 2020
Subclonal reconstruction of tumors by using machine learning and population genetics
Giulio Caravagna, Timon Heide, Marc J Williams, et al.
Cancer Letters
|
September 23, 2024
Spliceosomal vulnerability of MYCN-amplified neuroblastoma is contingent on PRMT5-mediated regulation of epitranscriptomic and metabolomic pathways
Jodie Bojko, Madhu Kollareddy, Marianna Szemes, et al.
Molecular Cancer Therapeutics
|
June 24, 2026
Anti-Tumor Activity of Cdk2/9 Inhibitor Fadraciclib in an In Vivo Model of Temozolomide Refractory Neuroblastoma
Evon Poon, Tong Liang, Qiong Gao, et al.
Cancer Research
|
October 3, 2007
Malignant progression and blockade of angiogenesis in a murine transgenic model of neuroblastoma
Louis Chesler, David D Goldenberg, Isha T Seales, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2012
Phase I study of vincristine, irinotecan, and ¹³¹I-metaiodobenzylguanidine for patients with relapsed or refractory neuroblastoma: a new approaches to neuroblastoma therapy trial
Steven G DuBois, Louis Chesler, Susan Groshen, et al.
Oncotarget
|
June 25, 2020
MYCN expression induces replication stress and sensitivity to PARP inhibition in neuroblastoma
David King, Xiao Dun Li, Gilberto S Almeida, et al.
Oncotarget
|
September 18, 2014
Molecular rationale for the use of PI3K/AKT/mTOR pathway inhibitors in combination with crizotinib in ALK-mutated neuroblastoma
Nathan F Moore, Anna M Azarova, Namrata Bhatnagar, et al.
Open Biology
|
December 1, 2021
MYC regulates metabolism through vesicular transfer of glycolytic kinases
Alexia Tsakaneli, Victor Corasolla Carregari, Martina Morini, et al.
Page
of 12